Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Sept 2026 for Kiniksa Pharmaceuticals International, plc. Read the official filing
Filing timeline
BuySaleMichael R. Megna
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael R. Megna: trading record in brief
Michael R. Megna (senior executive) discloses dealings in Kiniksa Pharmaceuticals International, plc to SEC (Form 4). Between 30 June 2020 and 3 September 2026, the trades on record add up to 39 filings.
No open-market purchase appears, only 2 sales worth €583k. Besides market trades, the filings include 13 share grants and 24 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 3 September 2026, reports an option exercise in Kiniksa Pharmaceuticals International, plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael R. Megna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
3,932 sharesClass A Ordinary ShareSEC:0001464583-26-000008:1
2,558 sharesClass A Ordinary ShareSEC:0001464583-26-000008:2
2,362 sharesClass A Ordinary ShareSEC:0001464583-26-000008:3
279 shares@ US$33.500.064% mcap0.5% of flowClass A Ordinary ShareSEC:0001464583-26-000008:0
5,531 shares@ US$79.282.95% mcap23.5% of flowClass A Ordinary ShareSEC:0001464583-26-000008:5
4,600 shares@ US$80.302.49% mcap19.8% of flowClass A Ordinary ShareSEC:0001464583-26-000008:6
2,644 sharesClass A Ordinary ShareSEC:0001464583-26-000008:4
6,625 shares@ US$46.6957.0% of flowClass A Ordinary ShareSEC:0001464583-26-000006:0
3,932 shares@ US$1.000.6% of flowClass A Ordinary ShareSEC:0001464583-26-000004:0
1,666 shares@ US$48.9413.0% of flowClass A Ordinary ShareSEC:0001464583-26-000004:1
372 shares@ US$24.161.1% of flowClass A Ordinary ShareSEC:0001464583-26-000002:0
3,205 shares@ US$48.1319.6% of flowClass A Ordinary ShareSEC:0001464583-26-000002:2
7,564 sharesClass A Ordinary ShareSEC:0001464583-26-000002:1
791 shares@ US$15.501.2% of flowClass A Ordinary ShareSEC:0001464583-25-000005:0
175 sharesClass A Ordinary ShareSEC:0001464583-25-000003:0
2,363 sharesClass A Ordinary ShareSEC:0001415889-25-023564:0
495 shares@ US$15.630.7% of flowClass A Ordinary ShareSEC:0001415889-25-021177:0
15,211 shares@ US$15.5023.4% of flowClass A Ordinary ShareSEC:0001415889-25-015782:0
229 shares@ US$8.830.9% of flowClass A Ordinary ShareSEC:0001415889-25-012532:0
3,933 sharesClass A Ordinary ShareSEC:0001415889-25-010476:0
2,557 sharesClass A Ordinary ShareSEC:0001415889-25-009991:0
469 shares@ US$16.003.7% of flowClass A Ordinary ShareSEC:0001415889-25-008618:0
9,051 shares@ US$11.1046.2% of flowClass A Ordinary ShareSEC:0001415889-25-008117:0
8,637 shares@ US$11.1045.8% of flowClass A Ordinary ShareSEC:0001415889-24-027993:0
175 sharesClass A Ordinary ShareSEC:0001415889-24-024885:0
25 of 39 declarations
